Atlas Trials

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Clinical trial NCT00744939 · COMPLETED

Trial details

NCT number
NCT00744939
Sponsor
Bayer
Status
COMPLETED
Study type
OBSERVATIONAL
FibrosisKidney FailureRenal Insufficiency
Start date
2008-11-01
Primary completion
2013-07-01
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.